Suppr超能文献

加拿大生物样本库访问的透明度:对行业访问以及访问政策和相关研究信息可用性的评估

Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.

作者信息

Gibson Shannon G, Axler Renata E, Lemmens Trudo

机构信息

1 University of Toronto, Ontario, Canada.

2 University of Windsor, Ontario, Canada.

出版信息

J Empir Res Hum Res Ethics. 2017 Dec;12(5):310-325. doi: 10.1177/1556264617723137. Epub 2017 Aug 17.

Abstract

A key issue impacting public trust in biobanks is how these resources are utilized, including who is given access to biobank data and samples. To assess the conditions under which researchers are given access to Canadian biobanks, we reviewed websites and contacted Canadian biobanks to determine the availability of information on access policies and procedures; research resulting from access biobank data and samples; and conditions on private industry access to biobanks. We also conducted expert interviews with key Canadian stakeholders ( n = 11) to obtain their perspectives on biobank transparency and access policies. Among 21 Canadian biobanks, there was wide variation in the access information made publicly available, and the majority of these allowed access by industry applicants. Biobanks should be governed by the principles of transparency, accountability, and accessibility, and attention must be given to the conditions around the commercialization of biobank-based research.

摘要

影响公众对生物样本库信任的一个关键问题是这些资源如何被利用,包括谁能够获取生物样本库的数据和样本。为了评估研究人员获取加拿大生物样本库资源的条件,我们查阅了相关网站,并联系了加拿大的生物样本库,以确定关于访问政策和程序的信息是否可得;利用生物样本库数据和样本开展的研究情况;以及私营行业访问生物样本库的条件。我们还对加拿大的主要利益相关者(n = 11)进行了专家访谈,以了解他们对生物样本库透明度和访问政策的看法。在21家加拿大生物样本库中,公开提供的访问信息差异很大,其中大多数允许行业申请者访问。生物样本库应以透明、问责和可及性原则进行管理,并且必须关注基于生物样本库研究商业化的相关条件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验